AstraZeneca, BenevolentAI join forces for AI-powered drug discovery

This article was originally published here

The collaboration will combine the genomics, chemistry and clinical data of AstraZeneca with the target identification platform and biomedical knowledge graph of BenevolentAI. BenevolentAI’s biomedical knowledge graph is

The post AstraZeneca, BenevolentAI join forces for AI-powered drug discovery appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply